Hertfordshire and West Essex ICB
Prescribing, Policies and Pathways
Prescribing, Policies and Pathways
or
| Medicine / Guideline | Indication | RAG rating | Document type | Place |
|---|---|---|---|---|
| Alimemazine | All indications, execluding sedation in paediatrics prior to diagnostic scans | Red | n/a | Hertfordshire and West Essex ICB |
| Amikacin | Cystic fibrosis (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Anaphylaxis Auto Adrenaline Injector | Anaphylaxis | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
| Asthma | MART | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Asthma | Inhaled corticosteroids (ICS) choices | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Asthma | Adults 18 years and over | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Asthma | Children 5 to 19 years | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Asthma | Step down guidance | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Azithromycin | COPD | Amber initiation | Prescribing support document | Hertfordshire and West Essex ICB |
| Aztreonam lysine | Cystic fibrosis chronic pseudomonas aeruginosa (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Benralizumab | Severe eosinophilic asthma (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Breathlessness | Non-Acute | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Bronchiectasis in Adults | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Colistimethate sodium (Colobreathe) | Cystic fibrosis (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Community LRTI Pneumonia Intravenous Antibiotic pathway for Housebound Care Home patients Pathway | n/a | Clinical pathways | East and North Hertfordshire | |
| COPD | COPD | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| COPD Pathway | n/a | Clinical pathways | East and North Hertfordshire | |
| COPD treatment guidelines | COPD | n/a | Decision document | Hertfordshire and West Essex ICB |
| Cough in Adults | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Cytisine | Smoking cessation | Double Red | n/a | Hertfordshire and West Essex ICB |
| Dornase alfa | Cystic fibrosis (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Gefapixant | Refractory or unexplained chronic cough | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Inhaled corticosteroids | Asthma COPD - ECF FAQs | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Inhaler - environmentally friendly | Asthma COPD | n/a | Patient information | Hertfordshire and West Essex ICB |
| Inhaler reliever | Asthma | n/a | Patient information | Hertfordshire and West Essex ICB |
| Isavuconazole | Antifungal (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Ivacaftor | Cystic fibrosis (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Kelhale inhaler | Asthma | Green | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Mannitol dry powder for inhalation | Cystic fibrosis (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Mechanical Insufflation-Exsufflation (MI-E) Devices / CoughAssist | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Palforzia | Peanut allergy (Specialist allergy centre) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Pirfenidone | Idiopathic pulmonary fibrosis (NHSE) | Red | Decision document | Hertfordshire and West Essex ICB |
| Pulmonary Rehabilitation | n/a | Clinical pathways | East and North Hertfordshire | |
| Referral and Surgery for Snoring, Sleep Disordered Breathing and Obstructive Sleep Apnoea | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
| Remdesivir | COVID‑19 | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Respiratory Conditions Referral Pathway | n/a | n/a | South and West Hertfordshire | |
| Roflumilast | COPD | Amber initiation | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Salamol - letter | Asthma COPD | Green | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Salamol - poster | Asthma COPD | Green | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
| Sildenafil (20mg tablets) | Pulmonary arterial hypertension (NHSE) | Red | n/a | Hertfordshire and West Essex ICB |
| Snoring and Sleep Apnoea Management in Adults | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
| Spacer | Asthma COPD | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
| Tixagevimab plus cilgavimab | COVID‑19 | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
| Tobramycin (TOBI Podhaler) | Cystic fibrosis (NHSE) | Red | NICE technology appraisal | Hertfordshire and West Essex ICB |